A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women

Vaccine

Volumn 30, Issue 36, 2012, Pages 5335-5340

  Sun, Kui Xia ^a   Li, Jie ^a   Zhu, Feng Cai ^b   Liu, Jian Xun ^c   Li, Rong Cheng ^d   Zhai, Xiang Jun ^b   Li, Yan Ping ^d   Chang, Zhan Jun ^c   Nie, Jing Jing ^a   Zhuang, Hui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Department of Major Projects   (China)

^d Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention   (China)

Author keywords

Hepatitis B e antigen; Hepatitis B virus DNA; Pregnant women; Quantitative HBsAg

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ACCURACY; ADOLESCENT; ARTICLE; DNA DETERMINATION; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; INFANT; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PREGNANT WOMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; VACCINATION; VIRUS LOAD;

ADOLESCENT; ADULT; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INFANT; INFANT, NEWBORN; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD; YOUNG ADULT;

EID: 84864013975     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.036     Document Type: Article

References (40)

1. Liang X.F., Bi S.L., Yang W.Z., Wang L.D., Cui G., Cui F.Q., et al. Epidemiological serosurvey of Hepatitis B in China-declining HBV prevalence due to Hepatitis B vaccination. Vaccine 2009, 27:6550-6557.
2. Yao J.L. Perinatal transmission of hepatitis B virus infection and vaccination in China. Gut 1996, 38:S37-S42.
3. Song Y.M., Sung J., Yang S., Choe Y.H., Chang Y.S., Park W.S., et al. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007, 166:813-818.
4. Shao Z.J., Xu D.Z., Xu J.Q., Li J.H., Yan Y.P., Men K., et al. Maternal hepatitis B virus (HBV) DNA positivity and sexual intercourse are associated with HBV intrauterine transmission in China: a prospective case-control study. J Gastroenterol Hepatol 2007, 22:165-170.
5. Koff R.S. Hepatitis vaccines: recent advances. Int J Parasitol 2003, 33:517-523.
6. Wang J.S., Zhu Q.R. Interruption of the transmission of hepatitis B virus from mothers to babies. Chin J Hepatol 2002, 10:308-310.
7. Singh A.E., Plitt S.S., Osiowy C., Surynicz K., Kouadjo E., Preiksaitis J., et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat 2011, 18:468-473.
8. Li X.M., Shi M.F., Yang Y.B., Shi Z.J., Hou H.Y., Shen H.M., et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004, 10:3215-3217.
9. Wiseman E., Fraser M.A., Holden S., Glass A., Kidson B.L., Heron L.G., et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009, 190:489-492.
10. Xu D.Z., Yan Y.P., C.Hoi B.C., Xu J.Q., Men K., Zhang J.X., et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002, 67:20-26.
11. Wang Z., Zhang J., Yang H., Li X., Wen S., Guo Y., et al. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003, 71:360-366.
12. Cadranel S., Zeghlache S., Fernandez S., Safary A., André F. Vaccination of newborns of HBsAg-positive carrier mothers with a recombinant DNA hepatitis B vaccine. Postgrad Med J 1987, 63:159-160.
13. Halliday M.L., Kang L.Y., Rankin J.G., Coates R.A., Corey P.N., Hu Z.H., et al. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China. Int J Epidemiol 1992, 21:564-573.
14. Han G.R., Cao M.K., Zhao W., Jiang H.X., Wang C.M., Bai S.F., et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011, 55:1215-1221.
15. Van Zonneveld M., Van Nunen A.B., Niesters H.G., de Man R.A., Schalm S.W., Janssen H.L. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003, 10:294-297.
16. Su T.H., Hsu C.S., Chen C.L., Liu C.H., Huang Y.W., Tseng T.C., et al. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. Antiviral Ther 2010, 15:1133-1139.
17. Sonneveld M.J., Rijckborst V., Boucher C.A., Hansen B.E., Janssen H.L. Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline. Hepatology 2010, 52:1251-1257.
18. Manesis E.K., Hadziyannis E.S., Angelopoulou O.P., Hadziyannis S.J. Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B: a clue from serum HBsAg levels. Antiviral Ther 2007, 12:73-82.
19. Tangkijvanich P., Komolmit P., Mahachai V., Sa-Nguanmoo P., Theamboonlers A., Poovorawan Y., et al. Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-a-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B. Hepatol Res 2010, 40:269-277.
20. Brunetto M.R., Oliveri F., Colombatto P., Moriconi F., Ciccorossi P., Coco B., et al. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology 2010, 139:483-490.
21. Kuhns M.C., Kleinman S.H., McNamara A.L., Rawal B., Glynn S., Busch M.P., et al. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion (Paris) 2004, 44:1332-1339.
22. Ozdil B., Cosar A.M., Akkiz H., Sandikci M.U., Kece C. Negative correlation between viral load and HBsAg levels in chronic HBV-infected patients. Arch Virol 2009, 154:1451-1455.
23. Wiegand J., Wedemeyer H., Finger A., Heidrich B., Rosenau J., Michel G., et al. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels. Antiviral Ther 2008, 13:547-554.
24. Deguchi M., Yamashita N., Kagita M., Asari S., Iwatani Y., Tsuchida T., et al. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods 2004, 115:217-222.
25. Ciotti M., Marcuccilli F., Guenci T., Prignano M.G., Perno C.F. Evaluation of the Abbott RealTime HBV DNA assay and comparison to the Cobas AmpliPrep/Cobas TaqMan 48 assay in monitoring patients with chronic cases of hepatitis B. J Clin Microbiol 2008, 46:1517-1519.
26. Jin H., Wang J., Yan L., Nie J.J., Li J., Zhuang H. Establishment of a nested PCR to identify hepatitis B virus genotypes A-D and subgenotypes B1, B2, C1 and C2. Chin J Epidemiol 2008, 29:1235-1239.
27. Maylin S., Boyd A., Delaugerre C., Zoulim F., Lavocat F., Simon F., et al. Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus. Clin Vaccine Immunol 2012, 19:242-248.
28. Wursthorn K., Jaroszewicz J., Zacher B.J., Darnedde M., Raupach R., Mederacke I., et al. Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum. J Clin Virol 2011, 50:292-296.
29. Guo Y., Liu J.Q., Meng L.P., Meina H., Du Y.K. Survey of HBsAg-positive pregnant women and their infants regarding measures to prevent maternal-infantile transmission. BMC Infect Dis 2010, 10:26.
30. Zhang S., Li R.T., Wang Y., Liu Q., Zhou Y.H., Hu Y., et al. Seroprevalence of hepatitis B surface antigen among pregnant women in Jiangsu, China, 17 years after introduction of hepatitis B vaccine. Int J Gynaecol Obstet 2010, 109:194-197.
31. Bai X.X., Zheng F., Miao M.F., Yang X.F. Survey on maternal and fetal effects of hepatitis B virus infection during pregnancy in Hangzhou. Chin J Epidemiol 2011, 32:203-204.
32. European Association for the Study of the Liver EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009, 50:227-242.
33. Lok A.S.F., McMahon B.J. Chronic hepatitis B. Hepatology 2007, 45:507-539.
34. Liaw Y.F., Leung N., Kao J.H., Piratvisuth T., Gane E., Han K.H., et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008, 2:263-283.
35. Chen C.H., Lee C.M., Wang J.H., Tung H.D., Hung C.H., Lu S.N. Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers. Eur J Gastroenterol Hepatol 2004, 16:1213-1218.
36. Thompson A.J., Nguyen T., Iser D., Ayres A., Jackson K., Littlejohn M., et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 2010, 51:1933-1944.
37. Ganji A., Esmaeilzadeh A., Ghafarzadegan K., Helalat H., Rafatpanah H., Mokhtarifar A. Correlation of quantitative assay of HBsAg and HBV DNA levels in chronic HBV. Hepat Monit 2011, 11:342-345.
38. Jaroszewicz J., Serrano B.C., Wursthorn K., Deterding K., Schlue J., Raupach R., et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 2010, 52:514-522.
39. Nguyen T., Thompson A.J., Bowden S., Croagh C., Bell S., Desmond P.V., et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 2010, 52:508-513.
40. Lee J.H., Kim S.J., Ahn S.H., Lee J., Park Y., Kim H.S. Correlation between quantitative serum HBsAg and HBV DNA test in Korean patients who showed high level of HBsAg. J Clin Pathol 2010, 63:1027-1031.